Home/Filings/4/0001739614-24-000011
4//SEC Filing

Deck Kelly 4

Accession 0001739614-24-000011

CIK 0001739614other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:20 PM ET

Size

5.5 KB

Accession

0001739614-24-000011

Insider Transaction Report

Form 4
Period: 2024-03-08
Deck Kelly
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-08$35.75/sh42,523$1,520,19738,020 total
    Exercise: $10.52Exp: 2028-11-26Common Stock (42,523 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.

Issuer

Inhibrx, Inc.

CIK 0001739614

Entity typeother

Related Parties

1
  • filerCIK 0001819427

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:20 PM ET
Size
5.5 KB